Not logged in Share Save
Share Save
Estimating the economic effect of harm associated with high risk prescribing of oral non-steroidal anti-inflammatory drugs in England: population based cohort and economic modelling study Camacho, Elizabeth M.; Penner, Leonie S.; Taylor, Amy; Guthrie, Bruce; Avery, Anthony J.; Ashcroft, Darren M.; Morales, Daniel R.; Rogers, Gabriel; Chuter, Antony; Elliott, Rachel A. Share Save
Share Save
Share Save
Estimating the cost-effectiveness of intermittently scanned continuous glucose monitoring in adults with type 1 diabetes in England Elliott, Rachel A.; Rogers, Gabriel; Evans, Mark L.; Neupane, Sankalpa; Rayman, Gerry; Lumley, Sarah; Cranston, Iain; Narendran, Parth; Sutton, Christopher J.; Taxiarchi, Vicky P.; Burns, Matthew; Thabit, Hood; Wilmot, Emma G.; Leelarathna, Lalantha Share Save
Share Save
Share Save
Share Save
Share Save
Share Save
Evolution of the evidence on the effectiveness and cost-effectiveness of acetylcholinesterase inhibitors and memantine for Alzheimer's disease: systematic review and economic model Hyde, Christopher; Peters, Jaime; Bond, Mary; Rogers, Gabriel; Hoyle, Martin; Anderson, Rob; Jeffreys, Mike; Davis, Sarah; Thokala, Praveen; Moxham, Tiffany Share Save
The effectiveness and cost-effectiveness of donepezil, galantamine, rivastigmine and memantine for the treatment of Alzheimer's disease (review of Technology Appraisal No. 111): a systematic review and economic model Bond, M.; Rogers, G.; Peters, J.; Anderson, R.; Hoyle, M.; Miners, A.; Moxham, T.; Davis, S.; Thokala, P.; Wailoo, A.; Jeffreys, M.; Hyde, C. Share Save
Share Save
Share Save
Share Save
Share Save
Share Save
Share Save
Share Save